Biodit AD (BUL:BDT)
Bulgaria · Delayed Price · Currency is BGN · Price in EUR 0.1000
0.00 (0.00%)
At close: Sep 9, 2026
Biodit AD Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.13 | 0.15 | 0.31 | 0.46 | 0.37 | 0.14 |
Other Revenue | -0 | - | - | - | - | 0.01 |
| 0.13 | 0.15 | 0.31 | 0.46 | 0.37 | 0.15 | |
Revenue Growth | -38.75% | -51.10% | -33.38% | 24.82% | 147.69% | 90.34% |
Cost of Revenue | 0.02 | 0.01 | 0.06 | 0.21 | 0.1 | 0.05 |
Gross Profit | 0.11 | 0.14 | 0.25 | 0.25 | 0.27 | 0.1 |
Selling, General & Admin | 0.31 | 0.33 | 0.48 | 0.47 | 0.46 | 0.23 |
Other Operating Expenses | - | - | -0 | -0.11 | -0.01 | - |
Operating Expenses | 0.31 | 0.33 | 0.48 | 0.36 | 0.44 | 0.23 |
Operating Income | -0.2 | -0.19 | -0.23 | -0.11 | -0.17 | -0.12 |
Interest Expense | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
Currency Exchange Gain (Loss) | -0 | -0 | -0 | 0 | -0 | -0 |
Other Non Operating Income (Expenses) | 0.01 | -0 | -0 | -0.01 | -0 | -0 |
EBT Excluding Unusual Items | -0.22 | -0.21 | -0.26 | -0.14 | -0.2 | -0.15 |
Other Unusual Items | - | - | 0 | 0 | - | - |
Pretax Income | -0.22 | -0.21 | -0.25 | -0.14 | -0.2 | -0.15 |
Income Tax Expense | - | - | -0.02 | -0.01 | -0.01 | -0.01 |
Net Income | -0.22 | -0.21 | -0.23 | -0.13 | -0.19 | -0.14 |
Net Income to Common | -0.22 | -0.21 | -0.23 | -0.13 | -0.19 | -0.14 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | - | 15 | 15 | 15 | 15 | 14 |
Shares Outstanding (Diluted) | - | 15 | 15 | 15 | 15 | 14 |
Shares Change | - | - | - | 1.14% | 7.32% | - |
EPS (Basic) | - | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
EPS (Diluted) | - | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.01 | -0.09 | -0.13 | -0.57 | -0.43 | -0.23 |
Free Cash Flow Per Share | - | -0.01 | -0.01 | -0.04 | -0.03 | -0.02 |
Gross Margin | 86.97% | 92.54% | 81.73% | 53.97% | 72.31% | 68.60% |
Operating Margin | -155.38% | -124.75% | -75.08% | -24.72% | -47.11% | -83.28% |
Profit Margin | -170.89% | -140.68% | -75.75% | -28.26% | -51.93% | -91.47% |
Free Cash Flow Margin | -8.95% | -57.63% | -41.20% | -122.41% | -114.60% | -152.22% |
EBITDA | -0.09 | -0.1 | -0.18 | -0.07 | -0.09 | -0.08 |
EBITDA Margin | -72.71% | -68.81% | -58.80% | -15.23% | -24.66% | -54.95% |
D&A For EBITDA | 0.11 | 0.08 | 0.05 | 0.04 | 0.08 | 0.04 |
EBIT | -0.2 | -0.19 | -0.23 | -0.11 | -0.17 | -0.12 |
EBIT Margin | -155.38% | -124.75% | -75.08% | -24.72% | -47.11% | -83.28% |
Revenue as Reported | 0.13 | 0.15 | 0.31 | 0.58 | 0.39 | 0.15 |